PhiChem（300398）株式概要ファイケム株式会社は、高性能材料ソリューションを提供しています。 詳細300398 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長1/6過去の実績4/6財務の健全性6/6配当金3/6報酬収益は年間19.54%増加すると予測されています 過去1年間で収益は58.4%増加しました リスク分析CN市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見る300398 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥38.0631.4% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture06b2016201920222025202620282031Revenue CN¥5.7bEarnings CN¥695.3mAdvancedSet Fair ValueView all narrativesPhiChem Corporation 競合他社Sanxiang Advanced MaterialsSymbol: SHSE:603663Market cap: CN¥27.1bGuangdong Dowstone TechnologySymbol: SZSE:300409Market cap: CN¥19.2bLuxi Chemical GroupSymbol: SZSE:000830Market cap: CN¥25.4bChangyu Holding GroupSymbol: SHSE:603407Market cap: CN¥24.0b価格と性能株価の高値、安値、推移の概要PhiChem過去の株価現在の株価CN¥38.0652週高値CN¥43.1052週安値CN¥17.89ベータ0.811ヶ月の変化23.65%3ヶ月変化13.88%1年変化94.58%3年間の変化117.61%5年間の変化131.65%IPOからの変化694.99%最新ニュースMajor Estimate Revision • May 14Consensus EPS estimates increase by 23%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥3.56b to CN¥3.68b. EPS estimate increased from CN¥0.86 to CN¥1.06 per share. Net income forecast to grow 53% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.91 to CN¥31.73. Share price rose 9.2% to CN¥39.12 over the past week.New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥35.82, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 113% over the past three years.Price Target Changed • Apr 22Price target increased by 17% to CN¥25.91Up from CN¥22.21, the current price target is an average from 2 analysts. New target price is 18% below last closing price of CN¥31.73. Stock is up 60% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.71 last year.Reported Earnings • Apr 22First quarter 2026 earnings released: EPS: CN¥0.23 (vs CN¥0.23 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.23 (in line with 1Q 2025). Revenue: CN¥872.7m (up 25% from 1Q 2025). Net income: CN¥131.2m (up 9.6% from 1Q 2025). Profit margin: 15% (down from 17% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China最新情報をもっと見るRecent updatesMajor Estimate Revision • May 14Consensus EPS estimates increase by 23%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥3.56b to CN¥3.68b. EPS estimate increased from CN¥0.86 to CN¥1.06 per share. Net income forecast to grow 53% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.91 to CN¥31.73. Share price rose 9.2% to CN¥39.12 over the past week.New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥35.82, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 113% over the past three years.Price Target Changed • Apr 22Price target increased by 17% to CN¥25.91Up from CN¥22.21, the current price target is an average from 2 analysts. New target price is 18% below last closing price of CN¥31.73. Stock is up 60% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.71 last year.Reported Earnings • Apr 22First quarter 2026 earnings released: EPS: CN¥0.23 (vs CN¥0.23 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.23 (in line with 1Q 2025). Revenue: CN¥872.7m (up 25% from 1Q 2025). Net income: CN¥131.2m (up 9.6% from 1Q 2025). Profit margin: 15% (down from 17% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai Chinaお知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥33.42, the stock trades at a forward P/E ratio of 48x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 73% over the past three years.お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026Reported Earnings • Oct 30Third quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.16 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.14 (down from CN¥0.16 in 3Q 2024). Revenue: CN¥879.5m (up 15% from 3Q 2024). Net income: CN¥74.1m (down 14% from 3Q 2024). Profit margin: 8.4% (down from 11% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥22.41, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 24% over the past three years.お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025New Risk • Sep 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥24.89, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 9.7% over the past three years.Buy Or Sell Opportunity • Aug 05Now 23% overvaluedOver the last 90 days, the stock has fallen 1.1% to CN¥20.35. The fair value is estimated to be CN¥16.49, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.Buy Or Sell Opportunity • Jul 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to CN¥19.72. The fair value is estimated to be CN¥16.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.Declared Dividend • Jul 06Dividend of CN¥0.065 announcedShareholders will receive a dividend of CN¥0.065. Ex-date: 8th July 2025 Payment date: 8th July 2025 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (17% cash payout ratio). The dividend has increased by an average of 10% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025Buy Or Sell Opportunity • Jun 25Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.5% to CN¥19.46. The fair value is estimated to be CN¥16.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.New Risk • Jun 13New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.9% average weekly change).Buy Or Sell Opportunity • Jun 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 18% to CN¥19.62. The fair value is estimated to be CN¥16.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.お知らせ • May 22PhiChem Corporation Approves Cash Dividend for 2024PhiChem Corporation held its Annual General Meeting of 2024 on 16 May 2025, approved cash dividend/10 shares (tax included): CNY 0.65000000 for 2024.New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥20.31, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 10% over the past three years.Buy Or Sell Opportunity • May 06Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 27% to CN¥20.31. The fair value is estimated to be CN¥16.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.Major Estimate Revision • Apr 29Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from CN¥0.70 to CN¥0.59 per share. Revenue forecast steady at CN¥3.42b. Net income forecast to grow 27% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target up from CN¥18.05 to CN¥20.33. Share price fell 5.3% to CN¥17.62 over the past week.お知らせ • Apr 25PhiChem Corporation Proposes Final Cash Dividend for the Year 2024PhiChem Corporation proposed final cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2024.Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.23 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.23 (up from CN¥0.11 in 1Q 2024). Revenue: CN¥700.6m (up 4.8% from 1Q 2024). Net income: CN¥119.7m (up 100% from 1Q 2024). Profit margin: 17% (up from 9.0% in 1Q 2024). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.お知らせ • Apr 23PhiChem Corporation, Annual General Meeting, May 16, 2025PhiChem Corporation, Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai Chinaお知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025分析記事 • Mar 25Getting In Cheap On PhiChem Corporation (SZSE:300398) Is UnlikelyWhen close to half the companies in the Chemicals industry in China have price-to-sales ratios (or "P/S") below 2.5x...お知らせ • Mar 22Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398).Shenmao Technology Inc (TWSE:3305) signed a letter of intent to acquire Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) for approximately CNY 230 million on September 27, 2024. Profound Material Technology Co., Ltd. had reported total assets of CNY 127.176 million, total owner’s equity of CNY 99.815 million, revenue of CNY 99.6654 million, operating profit of CNY 13.1983 million and net profit of CNY 10.5306 million on December 31, 2023. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board of Shenmao Technology Inc. Transaction has been approved by PhiChem Corporation's Board of director's and is still subject to approval from PhiChem Corporation's shareholders. As on January 6, 2025, PhiChem Corporation and Shenmao Technology signed the Share Purchase and Sale Agreement. Transaction is expected to complete on March 20, 2025. Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) on March 20, 2025.分析記事 • Feb 08PhiChem (SZSE:300398) Will Want To Turn Around Its Return TrendsWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025お知らせ • Dec 21PhiChem Corporation Announces Third Quarter 2024 Profit Distribution, Payable on 27 December 2024PhiChem Corporation announced 2024 third quarter profit distribution plan to be implemented (A shares): Cash dividend per 10 shares (tax included) of CNY 0.30000000. Record date: 26 December 2024; Ex-date: 27 December 2024; Payment date: 27 December 2024.分析記事 • Dec 02Subdued Growth No Barrier To PhiChem Corporation (SZSE:300398) With Shares Advancing 26%Despite an already strong run, PhiChem Corporation ( SZSE:300398 ) shares have been powering on, with a gain of 26% in...分析記事 • Nov 20PhiChem (SZSE:300398) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...お知らせ • Oct 30PhiChem Corporation Proposes Cash Dividend for the Third Quarter of 2024PhiChem Corporation announced on 29 October 2024 the profit distribution proposal for the third quarter of 2024 as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.069 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.16 (up from CN¥0.069 in 3Q 2023). Revenue: CN¥762.0m (up 7.5% from 3Q 2023). Net income: CN¥85.7m (up 138% from 3Q 2023). Profit margin: 11% (up from 5.1% in 3Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.分析記事 • Oct 08Optimistic Investors Push PhiChem Corporation (SZSE:300398) Shares Up 58% But Growth Is LackingPhiChem Corporation ( SZSE:300398 ) shareholders would be excited to see that the share price has had a great month...お知らせ • Sep 30PhiChem Corporation to Report Q3, 2024 Results on Oct 29, 2024PhiChem Corporation announced that they will report Q3, 2024 results on Oct 29, 2024分析記事 • Sep 05PhiChem's (SZSE:300398) Soft Earnings Are Actually Better Than They AppearThe market for PhiChem Corporation's ( SZSE:300398 ) shares didn't move much after it posted weak earnings recently...Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.19 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.19 in 2Q 2023). Revenue: CN¥740.3m (up 3.4% from 2Q 2023). Net income: CN¥60.3m (down 41% from 2Q 2023). Profit margin: 8.1% (down from 14% in 2Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.分析記事 • Aug 21PhiChem Corporation's (SZSE:300398) Price In Tune With EarningsWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") below 26x, you may consider...分析記事 • Jul 23PhiChem (SZSE:300398) Could Be Struggling To Allocate CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...お知らせ • Jul 11PhiChem Corporation Announces Final Dividend on A Shares for the Year 2023, Payable on July 16, 2024PhiChem Corporation announced final cash dividend/10 shares (tax included) of CNY 0.80000000 on A shares for the year 2023. Record date is July 15, 2024. Ex-date is July 16, 2024. Payment date is July 16, 2024.お知らせ • Jun 29PhiChem Corporation to Report First Half, 2024 Results on Aug 30, 2024PhiChem Corporation announced that they will report first half, 2024 results on Aug 30, 2024Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.32, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.New Risk • Jun 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥13.36, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years.分析記事 • May 25Is PhiChem (SZSE:300398) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • May 19New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.14 in 1Q 2023). Revenue: CN¥668.5m (up 11% from 1Q 2023). Net income: CN¥59.8m (down 17% from 1Q 2023). Profit margin: 9.0% (down from 12% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.お知らせ • Apr 30PhiChem Corporation, Annual General Meeting, May 21, 2024PhiChem Corporation, Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China分析記事 • Apr 18PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%The PhiChem Corporation ( SZSE:300398 ) share price has fared very poorly over the last month, falling by a substantial...Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥9.92, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 35% over the past three years.お知らせ • Mar 30PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024PhiChem Corporation announced that they will report Q1, 2024 results on Apr 29, 2024Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥14.84, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 2.4% over the past three years.分析記事 • Mar 04PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The CompanyThose holding PhiChem Corporation ( SZSE:300398 ) shares would be relieved that the share price has rebounded 29% in...分析記事 • Feb 26Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.26, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 20% over the past three years.お知らせ • Dec 30PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024PhiChem Corporation announced that they will report fiscal year 2023 results on Mar 30, 2024Price Target Changed • Nov 28Price target decreased by 10.0% to CN¥18.85Down from CN¥20.94, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥18.10. Stock is up 3.5% over the past year. The company is forecast to post earnings per share of CN¥0.71 for next year compared to CN¥0.84 last year.Valuation Update With 7 Day Price Move • Oct 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.70, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 5.2% over the past three years.New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.069 (down from CN¥0.13 in 3Q 2022). Revenue: CN¥708.6m (up 19% from 3Q 2022). Net income: CN¥36.0m (down 47% from 3Q 2022). Profit margin: 5.1% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Price Target Changed • Aug 26Price target decreased by 12% to CN¥20.94Down from CN¥23.87, the current price target is an average from 4 analysts. New target price is 41% above last closing price of CN¥14.88. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.84 last year.Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.22 in 2Q 2022). Revenue: CN¥715.8m (down 8.1% from 2Q 2022). Net income: CN¥102.0m (down 11% from 2Q 2022). Profit margin: 14% (in line with 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • Aug 23New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Board Change • Jun 25High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Deqing Meng was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 30PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023PhiChem Corporation announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.80000000 for the year 2022, payable on 02 June 2023. Record date is 01 June 2023. Ex-date is 02 June 2023.Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.27 in 1Q 2022). Revenue: CN¥601.7m (down 31% from 1Q 2022). Net income: CN¥72.4m (down 48% from 1Q 2022). Profit margin: 12% (down from 16% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Price Target Changed • Nov 16Price target decreased to CN¥19.50Down from CN¥33.18, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of CN¥18.68. Stock is down 3.7% over the past year. The company is forecast to post earnings per share of CN¥0.78 for next year compared to CN¥0.75 last year.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Major Estimate Revision • Nov 01Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥3.18b to CN¥2.92b. EPS estimate also fell from CN¥0.96 per share to CN¥0.78 per share. Net income forecast to shrink 0.03% next year vs 44% growth forecast for Chemicals industry in China . Consensus price target down from CN¥33.18 to CN¥19.50. Share price fell 3.0% to CN¥17.08 over the past week.Reported Earnings • Oct 26Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥595.3m (down 13% from 3Q 2021). Net income: CN¥67.8m (down 34% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.22 (up from CN¥0.20 in 2Q 2021). Revenue: CN¥779.1m (up 22% from 2Q 2021). Net income: CN¥114.3m (up 14% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.お知らせ • Jun 10PhiChem Corporation Announces Cash Dividend, Payable on 16 June 2022PhiChem Corporation announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.70000000. Record date as 15 June 2022, ex-date as 16 June 2022 and payment date as 16 June 2022.お知らせ • May 08PhiChem Corporation (SZSE:300398) announces an Equity Buyback for CNY 100 million worth of its shares.PhiChem Corporation (SZSE:300398) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at a price of CNY 41.53 per share. The purpose of the share repurchases will be used to implement the equity incentive plan. The share repurchases will be funded from company's own funds. The program is valid for 12 months.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Apr 22PhiChem Corporation Approves Final Cash Dividend for the Year 2021PhiChem Corporation at its Annual General Meeting of 2021 on 20 April 2022 approved cash dividend of CNY 0.7000000 (tax included) per 10 shares for 2021.Major Estimate Revision • Apr 06Consensus EPS estimates increase by 20%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥2.89b to CN¥3.18b. EPS estimate increased from CN¥0.80 to CN¥0.96 per share. Net income forecast to grow 30% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target up from CN¥27.50 to CN¥31.19. Share price fell 8.0% to CN¥26.66 over the past week.Reported Earnings • Apr 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥0.75 (up from CN¥0.45 in FY 2020). Revenue: CN¥2.63b (up 41% from FY 2020). Net income: CN¥385.9m (up 68% from FY 2020). Profit margin: 15% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Apr 02PhiChem Corporation, Annual General Meeting, Apr 20, 2022PhiChem Corporation, Annual General Meeting, Apr 20, 2022. Agenda: To discuss 2021 work report of the board of directors; to discuss 2021 work report of the supervisory committee; to discuss 2021 annual report and its summary; to discuss 2021 annual accounts; to discuss 2021 profit distribution plan; to discuss 2022 financial budget report; to discuss Reappointment of audit firm; and to discuss Application for comprehensive credit line in 2022 to financial institutions and enterprises and estimated guarantee quota.Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Apr 01PhiChem Corporation Proposes Final Cash Dividend for the Year 2021PhiChem Corporation proposed final cash dividend of CNY 0.70000000 per ten shares (tax included) for the year 2021.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.00, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 85% over the past three years.Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥26.45, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years.Reported Earnings • Nov 01Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥684.3m (up 33% from 3Q 2020). Net income: CN¥102.4m (up 73% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Aug 10Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥639.6m (up 39% from 2Q 2020). Net income: CN¥99.8m (up 72% from 2Q 2020). Profit margin: 16% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.お知らせ • May 26Shanghai Phichem Material Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on 31 May 2021Shanghai Phichem Material Co., Ltd. announced final cash dividend (tax included) of CNY 0.65000000 per 10 shares (A shares) for the year 2020. The dividend is payable on 31 May 2021 to shareholders on record of 28 May 2021 with ex-date as 31 May 2021.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥562.9m (up 53% from 1Q 2020). Net income: CN¥68.2m (up 30% from 1Q 2020). Profit margin: 12% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.お知らせ • Mar 20Shanghai Phichem Material Co., Ltd. Proposes Cash Dividend for the Year 2020Shanghai Phichem Material Co., Ltd. proposed cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2020.お知らせ • Mar 19Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021, at 14:30 China Standard Time. Agenda: To consider 2020 work report of the board of directors; to consider 2020 work report of the supervisory committee; to consider 2020 annual report and its summary; to consider 2020 annual accounts; to consider 2020 profit distribution plan; to consider 2021 financial budget report; to consider reappointment of audit firm; and to consider application for bank credit line in 2021.Reported Earnings • Mar 18Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.86b (up 23% from FY 2019). Net income: CN¥229.8m (down 9.9% from FY 2019). Profit margin: 12% (down from 17% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.お知らせ • Feb 18Shanghai Phichem Material Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021Shanghai Phichem Material Co., Ltd. announced that they will report fiscal year 2020 results on Mar 18, 2021株主還元300398CN ChemicalsCN 市場7D-2.9%-2.9%-1.5%1Y94.6%59.3%34.5%株主還元を見る業界別リターン: 300398過去 1 年間で59.3 % の収益を上げたCN Chemicals業界を上回りました。リターン対市場: 300398過去 1 年間で34.5 % の収益を上げたCN市場を上回りました。価格変動Is 300398's price volatile compared to industry and market?300398 volatility300398 Average Weekly Movement8.9%Chemicals Industry Average Movement6.9%Market Average Movement6.5%10% most volatile stocks in CN Market10.2%10% least volatile stocks in CN Market4.3%安定した株価: 300398の株価は、 CN市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 300398の weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてCNの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20022,104Jin Zhangwww.phichem.com.cnファイケム・コーポレーションは高性能材料ソリューションを提供している。光ファイバーやケーブルのコーティングに不可欠なベース樹脂からなるUV硬化型材料や、集積回路製造材料、ウェハーレベルパッケージング材料、チップレベルパッケージング材料、プリント配線板製造材料などの半導体材料を提供している。また、有機EL材料、液晶材料、フォトレジストなどのディスプレイ材料、医薬中間体や液晶モノマーなどの有機合成材料も提供している。旧社名は上海富化材料有限公司で、2021年7月にファイケム株式会社に社名変更した。同社は2002年に設立され、中国の上海に本社を置いている。もっと見るPhiChem Corporation 基礎のまとめPhiChem の収益と売上を時価総額と比較するとどうか。300398 基礎統計学時価総額CN¥21.58b収益（TTM）CN¥390.40m売上高(TTM)CN¥3.23b55.3xPER（株価収益率6.7xP/Sレシオ300398 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計300398 損益計算書（TTM）収益CN¥3.23b売上原価CN¥2.05b売上総利益CN¥1.17bその他の費用CN¥784.07m収益CN¥390.40m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）0.69グロス・マージン36.41%純利益率12.10%有利子負債／自己資本比率15.3%300398 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.3%現在の配当利回り17%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 07:21終値2026/05/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PhiChem Corporation 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedKai LiuEverbright Securities Co. Ltd.Wei LiuHaitong International Research Limited6 その他のアナリストを表示
Major Estimate Revision • May 14Consensus EPS estimates increase by 23%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥3.56b to CN¥3.68b. EPS estimate increased from CN¥0.86 to CN¥1.06 per share. Net income forecast to grow 53% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.91 to CN¥31.73. Share price rose 9.2% to CN¥39.12 over the past week.
New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥35.82, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 113% over the past three years.
Price Target Changed • Apr 22Price target increased by 17% to CN¥25.91Up from CN¥22.21, the current price target is an average from 2 analysts. New target price is 18% below last closing price of CN¥31.73. Stock is up 60% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.71 last year.
Reported Earnings • Apr 22First quarter 2026 earnings released: EPS: CN¥0.23 (vs CN¥0.23 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.23 (in line with 1Q 2025). Revenue: CN¥872.7m (up 25% from 1Q 2025). Net income: CN¥131.2m (up 9.6% from 1Q 2025). Profit margin: 15% (down from 17% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
Major Estimate Revision • May 14Consensus EPS estimates increase by 23%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥3.56b to CN¥3.68b. EPS estimate increased from CN¥0.86 to CN¥1.06 per share. Net income forecast to grow 53% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.91 to CN¥31.73. Share price rose 9.2% to CN¥39.12 over the past week.
New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥35.82, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 113% over the past three years.
Price Target Changed • Apr 22Price target increased by 17% to CN¥25.91Up from CN¥22.21, the current price target is an average from 2 analysts. New target price is 18% below last closing price of CN¥31.73. Stock is up 60% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.71 last year.
Reported Earnings • Apr 22First quarter 2026 earnings released: EPS: CN¥0.23 (vs CN¥0.23 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.23 (in line with 1Q 2025). Revenue: CN¥872.7m (up 25% from 1Q 2025). Net income: CN¥131.2m (up 9.6% from 1Q 2025). Profit margin: 15% (down from 17% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥33.42, the stock trades at a forward P/E ratio of 48x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 73% over the past three years.
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.16 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.14 (down from CN¥0.16 in 3Q 2024). Revenue: CN¥879.5m (up 15% from 3Q 2024). Net income: CN¥74.1m (down 14% from 3Q 2024). Profit margin: 8.4% (down from 11% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥22.41, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 24% over the past three years.
お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
New Risk • Sep 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥24.89, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 9.7% over the past three years.
Buy Or Sell Opportunity • Aug 05Now 23% overvaluedOver the last 90 days, the stock has fallen 1.1% to CN¥20.35. The fair value is estimated to be CN¥16.49, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.
Buy Or Sell Opportunity • Jul 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to CN¥19.72. The fair value is estimated to be CN¥16.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.
Declared Dividend • Jul 06Dividend of CN¥0.065 announcedShareholders will receive a dividend of CN¥0.065. Ex-date: 8th July 2025 Payment date: 8th July 2025 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (16% earnings payout ratio) and cash flows (17% cash payout ratio). The dividend has increased by an average of 10% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025
Buy Or Sell Opportunity • Jun 25Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.5% to CN¥19.46. The fair value is estimated to be CN¥16.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.
New Risk • Jun 13New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.9% average weekly change).
Buy Or Sell Opportunity • Jun 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 18% to CN¥19.62. The fair value is estimated to be CN¥16.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.
お知らせ • May 22PhiChem Corporation Approves Cash Dividend for 2024PhiChem Corporation held its Annual General Meeting of 2024 on 16 May 2025, approved cash dividend/10 shares (tax included): CNY 0.65000000 for 2024.
New Risk • May 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥20.31, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 10% over the past three years.
Buy Or Sell Opportunity • May 06Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 27% to CN¥20.31. The fair value is estimated to be CN¥16.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 40%. Revenue is forecast to grow by 41% in 2 years. Earnings are forecast to grow by 22% in the next 2 years.
Major Estimate Revision • Apr 29Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from CN¥0.70 to CN¥0.59 per share. Revenue forecast steady at CN¥3.42b. Net income forecast to grow 27% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target up from CN¥18.05 to CN¥20.33. Share price fell 5.3% to CN¥17.62 over the past week.
お知らせ • Apr 25PhiChem Corporation Proposes Final Cash Dividend for the Year 2024PhiChem Corporation proposed final cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2024.
Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.23 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.23 (up from CN¥0.11 in 1Q 2024). Revenue: CN¥700.6m (up 4.8% from 1Q 2024). Net income: CN¥119.7m (up 100% from 1Q 2024). Profit margin: 17% (up from 9.0% in 1Q 2024). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 23PhiChem Corporation, Annual General Meeting, May 16, 2025PhiChem Corporation, Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025
分析記事 • Mar 25Getting In Cheap On PhiChem Corporation (SZSE:300398) Is UnlikelyWhen close to half the companies in the Chemicals industry in China have price-to-sales ratios (or "P/S") below 2.5x...
お知らせ • Mar 22Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398).Shenmao Technology Inc (TWSE:3305) signed a letter of intent to acquire Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) for approximately CNY 230 million on September 27, 2024. Profound Material Technology Co., Ltd. had reported total assets of CNY 127.176 million, total owner’s equity of CNY 99.815 million, revenue of CNY 99.6654 million, operating profit of CNY 13.1983 million and net profit of CNY 10.5306 million on December 31, 2023. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board of Shenmao Technology Inc. Transaction has been approved by PhiChem Corporation's Board of director's and is still subject to approval from PhiChem Corporation's shareholders. As on January 6, 2025, PhiChem Corporation and Shenmao Technology signed the Share Purchase and Sale Agreement. Transaction is expected to complete on March 20, 2025. Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) on March 20, 2025.
分析記事 • Feb 08PhiChem (SZSE:300398) Will Want To Turn Around Its Return TrendsWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025
お知らせ • Dec 21PhiChem Corporation Announces Third Quarter 2024 Profit Distribution, Payable on 27 December 2024PhiChem Corporation announced 2024 third quarter profit distribution plan to be implemented (A shares): Cash dividend per 10 shares (tax included) of CNY 0.30000000. Record date: 26 December 2024; Ex-date: 27 December 2024; Payment date: 27 December 2024.
分析記事 • Dec 02Subdued Growth No Barrier To PhiChem Corporation (SZSE:300398) With Shares Advancing 26%Despite an already strong run, PhiChem Corporation ( SZSE:300398 ) shares have been powering on, with a gain of 26% in...
分析記事 • Nov 20PhiChem (SZSE:300398) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
お知らせ • Oct 30PhiChem Corporation Proposes Cash Dividend for the Third Quarter of 2024PhiChem Corporation announced on 29 October 2024 the profit distribution proposal for the third quarter of 2024 as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.069 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.16 (up from CN¥0.069 in 3Q 2023). Revenue: CN¥762.0m (up 7.5% from 3Q 2023). Net income: CN¥85.7m (up 138% from 3Q 2023). Profit margin: 11% (up from 5.1% in 3Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
分析記事 • Oct 08Optimistic Investors Push PhiChem Corporation (SZSE:300398) Shares Up 58% But Growth Is LackingPhiChem Corporation ( SZSE:300398 ) shareholders would be excited to see that the share price has had a great month...
お知らせ • Sep 30PhiChem Corporation to Report Q3, 2024 Results on Oct 29, 2024PhiChem Corporation announced that they will report Q3, 2024 results on Oct 29, 2024
分析記事 • Sep 05PhiChem's (SZSE:300398) Soft Earnings Are Actually Better Than They AppearThe market for PhiChem Corporation's ( SZSE:300398 ) shares didn't move much after it posted weak earnings recently...
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.19 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.19 in 2Q 2023). Revenue: CN¥740.3m (up 3.4% from 2Q 2023). Net income: CN¥60.3m (down 41% from 2Q 2023). Profit margin: 8.1% (down from 14% in 2Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
分析記事 • Aug 21PhiChem Corporation's (SZSE:300398) Price In Tune With EarningsWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") below 26x, you may consider...
分析記事 • Jul 23PhiChem (SZSE:300398) Could Be Struggling To Allocate CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
お知らせ • Jul 11PhiChem Corporation Announces Final Dividend on A Shares for the Year 2023, Payable on July 16, 2024PhiChem Corporation announced final cash dividend/10 shares (tax included) of CNY 0.80000000 on A shares for the year 2023. Record date is July 15, 2024. Ex-date is July 16, 2024. Payment date is July 16, 2024.
お知らせ • Jun 29PhiChem Corporation to Report First Half, 2024 Results on Aug 30, 2024PhiChem Corporation announced that they will report first half, 2024 results on Aug 30, 2024
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.32, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.
New Risk • Jun 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥13.36, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years.
分析記事 • May 25Is PhiChem (SZSE:300398) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • May 19New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.14 in 1Q 2023). Revenue: CN¥668.5m (up 11% from 1Q 2023). Net income: CN¥59.8m (down 17% from 1Q 2023). Profit margin: 9.0% (down from 12% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 30PhiChem Corporation, Annual General Meeting, May 21, 2024PhiChem Corporation, Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
分析記事 • Apr 18PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%The PhiChem Corporation ( SZSE:300398 ) share price has fared very poorly over the last month, falling by a substantial...
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥9.92, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 35% over the past three years.
お知らせ • Mar 30PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024PhiChem Corporation announced that they will report Q1, 2024 results on Apr 29, 2024
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥14.84, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 2.4% over the past three years.
分析記事 • Mar 04PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The CompanyThose holding PhiChem Corporation ( SZSE:300398 ) shares would be relieved that the share price has rebounded 29% in...
分析記事 • Feb 26Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.26, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 20% over the past three years.
お知らせ • Dec 30PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024PhiChem Corporation announced that they will report fiscal year 2023 results on Mar 30, 2024
Price Target Changed • Nov 28Price target decreased by 10.0% to CN¥18.85Down from CN¥20.94, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥18.10. Stock is up 3.5% over the past year. The company is forecast to post earnings per share of CN¥0.71 for next year compared to CN¥0.84 last year.
Valuation Update With 7 Day Price Move • Oct 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.70, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 5.2% over the past three years.
New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.069 (down from CN¥0.13 in 3Q 2022). Revenue: CN¥708.6m (up 19% from 3Q 2022). Net income: CN¥36.0m (down 47% from 3Q 2022). Profit margin: 5.1% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Price Target Changed • Aug 26Price target decreased by 12% to CN¥20.94Down from CN¥23.87, the current price target is an average from 4 analysts. New target price is 41% above last closing price of CN¥14.88. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.86 for next year compared to CN¥0.84 last year.
Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.22 in 2Q 2022). Revenue: CN¥715.8m (down 8.1% from 2Q 2022). Net income: CN¥102.0m (down 11% from 2Q 2022). Profit margin: 14% (in line with 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • Aug 23New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Board Change • Jun 25High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Deqing Meng was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 30PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023PhiChem Corporation announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.80000000 for the year 2022, payable on 02 June 2023. Record date is 01 June 2023. Ex-date is 02 June 2023.
Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.27 in 1Q 2022). Revenue: CN¥601.7m (down 31% from 1Q 2022). Net income: CN¥72.4m (down 48% from 1Q 2022). Profit margin: 12% (down from 16% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Price Target Changed • Nov 16Price target decreased to CN¥19.50Down from CN¥33.18, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of CN¥18.68. Stock is down 3.7% over the past year. The company is forecast to post earnings per share of CN¥0.78 for next year compared to CN¥0.75 last year.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Major Estimate Revision • Nov 01Consensus EPS estimates fall by 18%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥3.18b to CN¥2.92b. EPS estimate also fell from CN¥0.96 per share to CN¥0.78 per share. Net income forecast to shrink 0.03% next year vs 44% growth forecast for Chemicals industry in China . Consensus price target down from CN¥33.18 to CN¥19.50. Share price fell 3.0% to CN¥17.08 over the past week.
Reported Earnings • Oct 26Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥595.3m (down 13% from 3Q 2021). Net income: CN¥67.8m (down 34% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.22 (up from CN¥0.20 in 2Q 2021). Revenue: CN¥779.1m (up 22% from 2Q 2021). Net income: CN¥114.3m (up 14% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
お知らせ • Jun 10PhiChem Corporation Announces Cash Dividend, Payable on 16 June 2022PhiChem Corporation announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.70000000. Record date as 15 June 2022, ex-date as 16 June 2022 and payment date as 16 June 2022.
お知らせ • May 08PhiChem Corporation (SZSE:300398) announces an Equity Buyback for CNY 100 million worth of its shares.PhiChem Corporation (SZSE:300398) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at a price of CNY 41.53 per share. The purpose of the share repurchases will be used to implement the equity incentive plan. The share repurchases will be funded from company's own funds. The program is valid for 12 months.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Apr 22PhiChem Corporation Approves Final Cash Dividend for the Year 2021PhiChem Corporation at its Annual General Meeting of 2021 on 20 April 2022 approved cash dividend of CNY 0.7000000 (tax included) per 10 shares for 2021.
Major Estimate Revision • Apr 06Consensus EPS estimates increase by 20%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥2.89b to CN¥3.18b. EPS estimate increased from CN¥0.80 to CN¥0.96 per share. Net income forecast to grow 30% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target up from CN¥27.50 to CN¥31.19. Share price fell 8.0% to CN¥26.66 over the past week.
Reported Earnings • Apr 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥0.75 (up from CN¥0.45 in FY 2020). Revenue: CN¥2.63b (up 41% from FY 2020). Net income: CN¥385.9m (up 68% from FY 2020). Profit margin: 15% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Apr 02PhiChem Corporation, Annual General Meeting, Apr 20, 2022PhiChem Corporation, Annual General Meeting, Apr 20, 2022. Agenda: To discuss 2021 work report of the board of directors; to discuss 2021 work report of the supervisory committee; to discuss 2021 annual report and its summary; to discuss 2021 annual accounts; to discuss 2021 profit distribution plan; to discuss 2022 financial budget report; to discuss Reappointment of audit firm; and to discuss Application for comprehensive credit line in 2022 to financial institutions and enterprises and estimated guarantee quota.
Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Apr 01PhiChem Corporation Proposes Final Cash Dividend for the Year 2021PhiChem Corporation proposed final cash dividend of CNY 0.70000000 per ten shares (tax included) for the year 2021.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.00, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 85% over the past three years.
Valuation Update With 7 Day Price Move • Jan 04Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥26.45, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years.
Reported Earnings • Nov 01Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥684.3m (up 33% from 3Q 2020). Net income: CN¥102.4m (up 73% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 10Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥639.6m (up 39% from 2Q 2020). Net income: CN¥99.8m (up 72% from 2Q 2020). Profit margin: 16% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
お知らせ • May 26Shanghai Phichem Material Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on 31 May 2021Shanghai Phichem Material Co., Ltd. announced final cash dividend (tax included) of CNY 0.65000000 per 10 shares (A shares) for the year 2020. The dividend is payable on 31 May 2021 to shareholders on record of 28 May 2021 with ex-date as 31 May 2021.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥562.9m (up 53% from 1Q 2020). Net income: CN¥68.2m (up 30% from 1Q 2020). Profit margin: 12% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.
お知らせ • Mar 20Shanghai Phichem Material Co., Ltd. Proposes Cash Dividend for the Year 2020Shanghai Phichem Material Co., Ltd. proposed cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2020.
お知らせ • Mar 19Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021, at 14:30 China Standard Time. Agenda: To consider 2020 work report of the board of directors; to consider 2020 work report of the supervisory committee; to consider 2020 annual report and its summary; to consider 2020 annual accounts; to consider 2020 profit distribution plan; to consider 2021 financial budget report; to consider reappointment of audit firm; and to consider application for bank credit line in 2021.
Reported Earnings • Mar 18Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.86b (up 23% from FY 2019). Net income: CN¥229.8m (down 9.9% from FY 2019). Profit margin: 12% (down from 17% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
お知らせ • Feb 18Shanghai Phichem Material Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021Shanghai Phichem Material Co., Ltd. announced that they will report fiscal year 2020 results on Mar 18, 2021
